Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Klinik - Best Practice (JFKlin)
Rahmawati, Intan Rizqi
Unknown Affiliation
Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Evaluasi Kepatuhan Terapi Obat pada Pasien Diabetes Melitus di Rawat Jalan RSUP Fatmawati Rahmawati, Intan Rizqi; Dwi Yulianti
Jurnal Farmasi Klinik Best Practice Vol 3 No 1 (2024): Jurnal Farmasi Klinis Best Practice Volume 3 No. 1 Juni 2024
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v3i1.39

Abstract

Patient compliance in carrying out treatment has an important role in the success of treatment. Therefore, researchers need to evaluate compliance with diabetes mellitus medication use. This research is a cross-sectional observational study with prospective data collection. The research was conducted at the Outpatient Clinic of Fatmawati Hospital in September 2023 – November 2023 using the MMAS-8 method on 57 patients. From the results, it is known that there is a significant relationship between level of education, medical therapy, disease complications, behaviour of health workers, comorbidities and Hba1c on the level of patient compliance. The outcome of the study showed patients with a high level of compliance is 42.1% and a low level of compliance is 47.4%. Patients with high compliance had 38.6% polypharmacy in their medication therapy; had disease complications 33.3%; felt that the behaviour of health workers was friendly 42.1%; have no comorbidities 22.8%; and controlled HbA1C 40.3%.
Analisis Efektivitas Biaya Antara Non-Tunneled Hemodialysis Catheter dengan Tunneled Hemodialysis Catheter di RS Fatmawati Bulan Juni-Juli 2024: Analisis Efektivitas Biaya Antara Non-Tunneled Hemodialysis Catheter dengan Tunneled Hemodialysis Catheter di RS Fatmawati Bulan Juni-Juli 2024 Yulianti, Dwi; Rahmawati, Intan Rizqi
Jurnal Farmasi Klinik Best Practice Vol 3 No 2 (2024): Jurnal Farmasi Klinis Best Practice Volume 3 No. 2 Desember 2024
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v3i2.58

Abstract

Hemodialysis is one of the life-saving treatment for kidney failure. Hemodialysis catheters are an essential part of hemodialysis access, there are two types of catheter hemodialysis: non-tunneled hemodialysis catheter and tunneled hemodialysis catheter. Hemodialysis catheter sometimes causes complications include infection or dysfunction. Therefore, researchers need to determine the Cost Effectiveness Analysis of non-tunneled hemodialysis catheter and tunneled hemodialysis catheter. This research is descriptive study with retrospective data collection from patient medical record and hospital billing. The research was conducted on inpatients with the installation of non-tunneled hemodialysis catheter and tunneled hemodialysis catheter at Fatmawati Hospital in June-July 2024 using Average Cost Effectiveness Ratio and Incremental Cost Effectiveness Ratio methods. From the result, patient who used hemodialysis catheters at Fatmawati Hospital were more male (54%) with an age group of <65 years (87%). The most comorbidities are diabetes mellitus, hypertension and anemia with 25,72% each. Tunneled hemodialysis catheter is the most cost effective for supporting hemodialysis in patients with end stage chronic kidney disease at Fatmawati Hospital, as evidenced by a smaller ACER value Rp. 362,691 and a negative ICER value -3,299,583 and include category of cost effectivess grid G cells which means dominant in cost effectiveness.
Co-Authors DWI YULIANTI